Navigation Links
PTC Therapeutics to Host Conference Call to Discuss Second Quarter 2014 Financial Results
Date:7/24/2014

SOUTH PLAINFIELD, N.J., July 24, 2014 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that the Company will host a webcast conference call to report its second quarter 2014 financial results and provide an update on the company's business and outlook on Thursday, August 7, 2014 at 8:30 a.m. (ET) before the opening of the market.

The call can be accessed by dialing (877) 303-9216 (domestic) or (973) 935-8152 (international) five minutes prior to the start of the call and providing the passcode 75347535. A live, listen-only webcast of the conference call can be accessed on the investor relations section of the PTC website at www.ptcbio.com. A webcast replay of the call will be available approximately two hours after completion of the call and will be archived on the company's website for two weeks.

About PTC Therapeutics, Inc.
PTC is a biopharmaceutical company focused on the discovery and development of orally administered, proprietary small molecule drugs that target post-transcriptional control processes. Post-transcriptional control processes regulate the rate and timing of protein production and are essential to proper cellular function. PTC's internally discovered pipeline addresses multiple therapeutic areas, including rare disorders, oncology and infectious diseases. PTC has developed proprietary technologies that it applies in its drug discovery activities and in collaborations with leading biopharmaceutical companies. For more information on the company, please visit our website www.ptcbio.com.

Logo - http://photos.prnewswire.com/prnh/20010919/PTCLOGO


'/>"/>
SOURCE PTC Therapeutics, Inc.
Copyright©2014 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Lightlake Therapeutics Inc. Files Investigational New Drug Application For Naloxone Nasal Spray For Reversing Opioid Overdose And Announces A Further Collaboration With The National Institute On Drug Abuse
2. Particle Sciences and Eyeon Therapeutics Receive Patent on Novel Dry Eye Technology
3. MultiCell Technologies Files Patent Application Covering New Class of RNA Therapeutics
4. Echo Therapeutics to Present at the Noble Financial Capital Markets Tenth Annual Equity Conference
5. Spark Therapeutics Achieves Recruitment Goal in Phase 3 Gene Therapy Clinical Study for Inherited Blindness
6. Echo Therapeutics Hires Product Development Management Executive
7. Cell Therapeutics Announces 2014 Outlook and Recent Drug Portfolio Progress
8. Halozyme Therapeutics Provides an Update on Anticipated Milestones for 2014 at the 32nd Annual J. P. Morgan Healthcare Conference
9. Lilly Announces Acquisition of CGRP Antibody for Migraine Prevention from Arteaus Therapeutics
10. ImmunoCellular Therapeutics Provides Update on 2014 Corporate Strategies and Milestones
11. Arcturus Therapeutics, Inc. Announces an RNAi Therapeutic Targeting Transthyretin-mediated Amyloidosis as its Flagship Program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/31/2015)... YORK , March 31, 2015 Immune ... announced today that it intends to expand its planned ... human monoclonal antibody targeting eotaxin-1. Bullous Pemphigoid is an ... 60,000 patients in the US and Europe ... to start enrolling patients in a Phase II clinical ...
(Date:3/31/2015)...  CVS Health (NYSE: CVS ) announced ... with Rush University Medical Center in ... in Tucson, Arizona and ... affiliations will help enhance access to high-quality, affordable ... affiliations, CVS Health will provide prescription and visit ...
(Date:3/31/2015)... , Mar. 27, 2015 Research and Markets ... addition of the "European Laboratory Information System ... by Type (Clinical Pathology Laboratory Information System, Anatomic ... report to their offering. The ... grow at a CAGR of 7.6% from 2014 ...
Breaking Medicine Technology:Immune Pharmaceuticals To Expand Bullous Pemphigoid Clinical Development Plan For Bertilimumab 2Immune Pharmaceuticals To Expand Bullous Pemphigoid Clinical Development Plan For Bertilimumab 3Immune Pharmaceuticals To Expand Bullous Pemphigoid Clinical Development Plan For Bertilimumab 4CVS Health Announces New Clinical Affiliations with Leading Medical Centers in Arizona and Illinois 2CVS Health Announces New Clinical Affiliations with Leading Medical Centers in Arizona and Illinois 3European Laboratory Information System Market Report 2015: Germany holds a larger share of the laboratory information systems market 2European Laboratory Information System Market Report 2015: Germany holds a larger share of the laboratory information systems market 3
(Date:3/31/2015)... Scotch Plains, NJ (PRWEB) March 31, 2015 ... breast care to all patients in a calm and caring ... specialists in the diagnosis and surgical treatment of breast cancer. ... the tri-state area but from all over the world. ... national and local publications. , The seeds for Summit Breast ...
(Date:3/31/2015)... Researchers at UC Davis have ... how human livers heal. The difference centers on ... Normally, mouse PPARa is far more active and ... quickly regenerate damaged livers. However, the research shows ... boost the regenerative effects of human PPARa. The ...
(Date:3/31/2015)... Portland, OR (PRWEB) March 31, 2015 Former ... retirement announcement than during his first year of a promising ... , Sports on Earth Senior Writer Will Leitch ... on the league. Leitch talks about the decision making process ... choosing the preservation of health over a large paycheck, and ...
(Date:3/31/2015)... Exton, PA (PRWEB) March 31, 2015 ... to the physical, social and psychological benefits of ... about the thousands of adaptive sports athletes that ... United States, encourage support for inclusive fitness and ... individuals interested in participating in adaptive sports and ...
(Date:3/31/2015)... 2015 Nutrition 21, LLC (“Nutrition ... new clinical study results supporting the efficacy of ... “Arginine Silicate Supplementation Decreases Markers of Cardiovascular, Renal ... and Cardiovascular Health in Healthy Adult Males.” The ... at the acclaimed Experimental Biology 2015 annual meeting ...
Breaking Medicine News(10 mins):Health News:Summit Breast Care is Celebrating Four Years as "NJ Top Docs" 2Health News:UC Davis Study Finds Protein May Improve Liver Regeneration 2Health News:UC Davis Study Finds Protein May Improve Liver Regeneration 3Health News:UC Davis Study Finds Protein May Improve Liver Regeneration 4Health News:Will Leitch and the Curious Case of Chris Borland on SCI TV 2Health News:Will Leitch and the Curious Case of Chris Borland on SCI TV 3Health News:April is National Adaptive Sports Month 2Health News:April is National Adaptive Sports Month 3Health News:Nutrition 21, LLC Announces the Presentation of Proteomic Results of a Nitrosigine® Clinical Study at the Renowned Experimental Biology 2015 Annual Meeting 2Health News:Nutrition 21, LLC Announces the Presentation of Proteomic Results of a Nitrosigine® Clinical Study at the Renowned Experimental Biology 2015 Annual Meeting 3Health News:Nutrition 21, LLC Announces the Presentation of Proteomic Results of a Nitrosigine® Clinical Study at the Renowned Experimental Biology 2015 Annual Meeting 4Health News:Nutrition 21, LLC Announces the Presentation of Proteomic Results of a Nitrosigine® Clinical Study at the Renowned Experimental Biology 2015 Annual Meeting 5Health News:Nutrition 21, LLC Announces the Presentation of Proteomic Results of a Nitrosigine® Clinical Study at the Renowned Experimental Biology 2015 Annual Meeting 6
... , - Misys BankFusion Universal Banking at the ... MSY.L), the global application software and services,company, today announces ... Banking., Government owned until 1996, CRDB Bank is ... 10 new branches a year, launch a fully,automated and ...
... with proven results. Women have seen increases of ½ to 2 ... comes from a blend of 13 different herbs, all of which ... effective for natural breast enhancement. , ... Port St. ...
... Intelligent Document Solutions to Speed Up Vision Plan ... Claim Processes, Improves ... August 18 /PRNewswire-FirstCall/,-- Autonomy Corporation plc (LSE: AU. ... the enterprise, today announced that General,Vision Services (GVS) ...
... of interpersonal conflict have a three-fold greater risk of ... to a new study by University of California, Davis, ... have never had a diagnosis of depression. , ... (EDT) poster session, "Improving Our Practice -- ,Focus on ...
... urged psychologists today to take a leading role ... upon the profession to provide "appropriate, nondiscriminatory treatment ... more research into all aspects of gender identity ... Annual Convention when the association,s governing Council of ...
... high performance mass spectrometry products and applications for proteomics at the ... ... The Netherlands (Business Wire EON) August 17, 2008 -- maXis™ ... mass spectrometer platform, and truly represents a revolution in tandem mass ...
Cached Medicine News:Health News:CRDB Bases Growth Strategy on Misys BankFusion Platform 2Health News:CRDB Bases Growth Strategy on Misys BankFusion Platform 3Health News:Zoft Breast Enhancement Gum Revolutionizes Breast Enhancement Industry 2Health News:Zoft Breast Enhancement Gum Revolutionizes Breast Enhancement Industry 3Health News:General Vision Services Standardizes on Autonomy to Automate Third-Party Administration Processes for Vision Care Services 2Health News:General Vision Services Standardizes on Autonomy to Automate Third-Party Administration Processes for Vision Care Services 3Health News:General Vision Services Standardizes on Autonomy to Automate Third-Party Administration Processes for Vision Care Services 4Health News:Suicide in Asian Americans 2Health News:APA resolves to play leading role in improving treatment for gender-variant people 2Health News:APA resolves to play leading role in improving treatment for gender-variant people 3Health News: Bruker Daltonics Showcasing Novel Proteomics Solutions Based on Mass Spectrometry at the 7th HUPO World Congress 2008 2Health News: Bruker Daltonics Showcasing Novel Proteomics Solutions Based on Mass Spectrometry at the 7th HUPO World Congress 2008 3Health News: Bruker Daltonics Showcasing Novel Proteomics Solutions Based on Mass Spectrometry at the 7th HUPO World Congress 2008 4
... a concise yet complete eTextbook of ... cardiovascular disease. In addition to the ... a full desktop version is included ... to the electronic textbook, Redi-Reference provides ...
ECG pocket is a handy reference for identifying common ECG findings....
... Reviews enable all those involved with healthcare ... the very latest evidence in their field ... harder each year as the volume of ... by delivering the best single source available ...
... Anatomy Flash Cards is ... the heart, veins, and ... system. It uses the ... images from BryanEdwards.com and ...
Medicine Products: